Market Leadership Acelity is the global leader in negative pressure wound therapy and collagen dressings, offering extensive product lines that cater to hospitals, clinics, and home care providers, presenting multiple avenues for cross-selling and new client acquisition.

Recent Product Launches With innovations like the PREVENA RESTOR AXIO*FORM Incision Management System and V.A.C. launched in 2020 and 2021, Acelity continues to expand its product portfolio, creating opportunities to upsell and build relationships with healthcare providers seeking advanced wound care solutions.

Strategic Acquisition Following its acquisition by 3M Healthcare in 2021 for $6.7 billion, Acelity’s integration into a larger healthcare conglomerate presents potential for leveraging broader distribution channels and tapping into existing 3M customer networks for increased sales.

Digital Engagement Acelity’s deployment of targeted digital tools including mobile apps like Nurse2Nurse and online product information indicates readiness for digital marketing campaigns and remote engagement strategies to reach wound care professionals more effectively.

Global Expansion Operating in more than 90 countries, Acelity’s widespread presence suggests opportunities to expand geographic reach through localized sales strategies, especially in emerging markets with growing needs for innovative wound management therapies.